Activities of cardiac tissue matrix metalloproteinases 2 and 9 are reduced by remote ischemic preconditioning in cardiosurgical patients with cardiopulmonary bypass

Journal of Translational Medicine

Volumn 12, Issue 1, 2014, Pages

  Zitta, Karina ^a   Meybohm, Patrick ^a,b   Bein, Berthold ^a   Gruenewald, Matthias ^a   Lauer, Fabian ^a   Steinfath, Markus ^a   Cremer, Jochen ^a   Zacharowski, Kai ^b   Albrecht, Martin ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Cardioprotection; Ischemia reperfusion injury; Matrix metalloproteinases; Myocardial damage; Remote ischemic preconditioning

Indexed keywords

GELATINASE A; GELATINASE B; TROPONIN T;

AGED; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GELATIN ZYMOGRAPHY; HEART INJURY; HEART PROTECTION; HUMAN; HUMAN TISSUE; ISCHEMIC PRECONDITIONING; MALE; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMOTE ISCHEMIC PRECONDITIONING; REPERFUSION INJURY; SURGICAL PATIENT; TISSUE LEVEL; ZYMOGRAPHY; BLOOD; CORONARY ARTERY BYPASS GRAFT; ENZYMOLOGY; HEART MUSCLE; METABOLISM; MIDDLE AGED;

AGED; CORONARY ARTERY BYPASS; FEMALE; HUMANS; ISCHEMIC PRECONDITIONING; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; MYOCARDIUM; TROPONIN T;

EID: 84899957544     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-12-94     Document Type: Article

References (42)

1. Gottesman RF, McKhann GM, Hogue CW. Neurological complications of cardiac surgery. Semin Neurol 2008, 28:703-715. 10.1055/s-0028-1105973, 19115176.
2. Newman MF, Wolman R, Kanchuger M, Marschall K, Mora-Mangano C, Roach G, Smith LR, Aggarwal A, Nussmeier N, Herskowitz A, Mangano DT. Multicenter preoperative stroke risk index for patients undergoing coronary artery bypass graft surgery. Multicenter Study of Perioperative Ischemia (McSPI) Research Group. Circulation 1996, 94:II74-II80.
3. Heusch G, Musiolik J, Kottenberg E, Peters J, Jakob H, Thielmann M. STAT5 activation and cardioprotection by remote ischemic preconditioning in humans: short communication. Circ Res 2012, 110:111-115. 10.1161/CIRCRESAHA.111.259556, 22116817.
4. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986, 74:1124-1136. 10.1161/01.CIR.74.5.1124, 3769170.
5. Gross ER, Gross GJ. Ischemic preconditioning and myocardial infarction: an update and perspective. Drug Discov Today Dis Mech 2007, 4:165-174. 2515553, 18701939.
6. Hausenloy DJ, Boston-Griffiths E, Yellon DM. Cardioprotection during cardiac surgery. Cardiovasc Res 2012, 94:253-265. 10.1093/cvr/cvs131, 3331616, 22440888.
7. Heusch G, Boengler K, Schulz R. Cardioprotection: nitric oxide, protein kinases, and mitochondria. Circulation 2008, 118:1915-1919. 10.1161/CIRCULATIONAHA.108.805242, 18981312.
8. Heusch G. Cardioprotection: chances and challenges of its translation to the clinic. Lancet 2013, 381:166-175. 10.1016/S0140-6736(12)60916-7, 23095318.
9. Ali ZA, Callaghan CJ, Lim E, Ali AA, Nouraei SA, Akthar AM, Boyle JR, Varty K, Kharbanda RK, Dutka DP, Gaunt ME. Remote ischemic preconditioning reduces myocardial and renal injury after elective abdominal aortic aneurysm repair: a randomized controlled trial. Circulation 2007, 116:I98-I105.
10. Cheung MM, Kharbanda RK, Konstantinov IE, Shimizu M, Frndova H, Li J, Holtby HM, Cox PN, Smallhorn JF, Van Arsdell GS, Redington AN. Randomized controlled trial of the effects of remote ischemic preconditioning on children undergoing cardiac surgery: first clinical application in humans. J Am Coll Cardiol 2006, 47:2277-2282. 10.1016/j.jacc.2006.01.066, 16750696.
11. Gunaydin B, Cakici I, Soncul H, Kalaycioglu S, Cevik C, Sancak B, Kanzik I, Karadenizli Y. Does remote organ ischaemia trigger cardiac preconditioning during coronary artery surgery?. Pharmacol Res 2000, 41:493-496. 10.1006/phrs.1999.0611, 10704275.
12. Hausenloy DJ, Mwamure PK, Venugopal V, Harris J, Barnard M, Grundy E, Ashley E, Vichare S, Di Salvo C, Kolvekar S, Hayward M, Keogh B, MacAllister RJ, Yellon DM. Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial. Lancet 2007, 370:575-579. 10.1016/S0140-6736(07)61296-3, 17707752.
13. Hoole SP, Heck PM, Sharples L, Khan SN, Duehmke R, Densem CG, Clarke SC, Shapiro LM, Schofield PM, O'Sullivan M, Dutka DP. Cardiac Remote Ischemic Preconditioning in Coronary Stenting (CRISP Stent) Study: a prospective, randomized control trial. Circulation 2009, 119:820-827. 10.1161/CIRCULATIONAHA.108.809723, 19188504.
14. Kharbanda RK, Li J, Konstantinov IE, Cheung MM, White PA, Frndova H, Stokoe J, Cox P, Vogel M, Van Arsdell G, MacAllister R, Redington AN. Remote ischaemic preconditioning protects against cardiopulmonary bypass-induced tissue injury: a preclinical study. Heart 2006, 92:1506-1511. 10.1136/hrt.2004.042366, 1861036, 16818489.
15. Thielmann M, Kottenberg E, Kleinbongard P, Wendt D, Gedik N, Pasa S, Price V, Tsagakis K, Neuhauser M, Peters J, Jakob H, Heusch G. Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: a single-centre randomised, double-blind, controlled trial. Lancet 2013, 382:597-604. 10.1016/S0140-6736(13)61450-6, 23953384.
16. Albrecht M, Zitta K, Bein B, Wennemuth G, Broch O, Renner J, Schuett T, Lauer F, Maahs D, Hummitzsch L, Cremer J, Zacharowski K, Meybohm P. Remote ischemic preconditioning regulates HIF-1alpha levels, apoptosis and inflammation in heart tissue of cardiosurgical patients: a pilot experimental study. Basic Res Cardiol 2013, 108:314.
17. Stocker W, Grams F, Baumann U, Reinemer P, Gomis-Ruth FX, McKay DB, Bode W. The metzincins-topological and sequential relations between the astacins, adamalysins, serralysins, and matrixins (collagenases) define a superfamily of zinc-peptidases. Protein Sci 1995, 4:823-840. 2143131, 7663339.
18. Phatharajaree W, Phrommintikul A, Chattipakorn N. Matrix metalloproteinases and myocardial infarction. Can J Cardiol 2007, 23:727-733. 10.1016/S0828-282X(07)70818-8, 2651917, 17622396.
19. Liu P, Sun M, Sader S. Matrix metalloproteinases in cardiovascular disease. Can J Cardiol 2006, 22(Suppl B):25B-30B. 2780831, 16498509.
20. Page-McCaw A, Ewald AJ, Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 2007, 8:221-233. 10.1038/nrm2125, 2760082, 17318226.
21. Meybohm P, Renner J, Broch O, Caliebe D, Albrecht M, Cremer J, Haake N, Scholz J, Zacharowski K, Bein B. Postoperative neurocognitive dysfunction in patients undergoing cardiac surgery after remote ischemic preconditioning: a double-blind randomized controlled pilot study. PLoS One 2013, 8:e64743-e64743. 10.1371/journal.pone.0064743, 3669352, 23741380.
22. Licka M, Zimmermann R, Zehelein J, Dengler TJ, Katus HA, Kubler W. Troponin T concentrations 72 hours after myocardial infarction as a serological estimate of infarct size. Heart 2002, 87:520-524. 10.1136/heart.87.6.520, 1767131, 12010931.
23. Albrecht M, Gruenewald M, Zitta K, Zacharowski K, Scholz J, Bein B, Meybohm P. Hypothermia and anesthetic postconditioning influence the expression and activity of small intestinal proteins possibly involved in ischemia/reperfusion-mediated events following cardiopulmonary resuscitation. Resuscitation 2012, 83:113-118. 10.1016/j.resuscitation.2011.06.038, 21763251.
24. Zitta K, Meybohm P, Bein B, Heinrich C, Renner J, Cremer J, Steinfath M, Scholz J, Albrecht M. Serum from patients undergoing remote ischemic preconditioning protects cultured human intestinal cells from hypoxia-induced damage: involvement of matrixmetalloproteinase-2 and -9. Mol Med 2012, 18:29-37. 3269643, 22009279.
25. Spearman C. The proof and measurement of association between two things. By C. Spearman, 1904. Am J Psychol 1987, 100:441-471. 10.2307/1422689, 3322052.
26. Wissler C. The Spearman Correlation Formula. Science 1905, 22:309-311. 10.1126/science.22.558.309, 17836577.
27. Kociol RD, Pang PS, Gheorghiade M, Fonarow GC, O'Connor CM, Felker GM. Troponin elevation in heart failure prevalence, mechanisms, and clinical implications. J Am Coll Cardiol 2010, 56:1071-1078. 10.1016/j.jacc.2010.06.016, 20863950.
28. Mair P, Mair J, Seibt I, Wieser C, Furtwaengler W, Waldenberger F, Puschendorf B, Balogh D. Cardiac troponin T: a new marker of myocardial tissue damage in bypass surgery. J Cardiothorac Vasc Anesth 1993, 7:674-678. 10.1016/1053-0770(93)90051-L, 8305656.
29. Lim SY, Hausenloy DJ. Remote ischemic conditioning: from bench to bedside. Front Physiol 2012, 3:27. 3282534, 22363297.
30. Hausenloy DJ. Cardioprotection techniques: preconditioning, postconditioning and remote con-ditioning (Basic Science). Curr Pharm Des 2013, 19:4544-4563. 10.2174/1381612811319250004, 23270554.
31. Hausenloy DJ, Yellon DM. Preconditioning and postconditioning: underlying mechanisms and clinical application. Atherosclerosis 2009, 204:334-341. 10.1016/j.atherosclerosis.2008.10.029, 19081095.
32. Sadat U. Signaling pathways of cardioprotective ischemic preconditioning. Int J Surg 2009, 7:490-498. 10.1016/j.ijsu.2009.06.004, 19540944.
33. Spinale FG. Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. Physiol Rev 2007, 87:1285-1342. 10.1152/physrev.00012.2007, 17928585.
34. Gallagher GL, Jackson CJ, Hunyor SN. Myocardial extracellular matrix remodeling in ischemic heart failure. Front Biosci 2007, 12:1410-1419. 10.2741/2157, 17127391.
35. Mukherjee R, Mingoia JT, Bruce JA, Austin JS, Stroud RE, Escobar GP, McClister DM, Allen CM, Alfonso-Jaume MA, Fini ME, Lovett DH, Spinale FG. Selective spatiotemporal induction of matrix metalloproteinase-2 and matrix metalloproteinase-9 transcription after myocardial infarction. Am J Physiol Heart Circ Physiol 2006, 291:H2216-H2228. 10.1152/ajpheart.01343.2005, 16766634.
36. Meybohm P, Gruenewald M, Albrecht M, Zacharowski KD, Lucius R, Zitta K, Koch A, Tran N, Scholz J, Bein B. Hypothermia and postconditioning after cardiopulmonary resuscitation reduce cardiac dysfunction by modulating inflammation, apoptosis and remodeling. PLoS One 2009, 4:e7588. 10.1371/journal.pone.0007588, 2764338, 19855846.
37. Baehner T, Boehm O, Probst C, Poetzsch B, Hoeft A, Baumgarten G, Knuefermann P. [Cardiopulmonary bypass in cardiac surgery]. Anaesthesist 2012, 61:846-856. 10.1007/s00101-012-2050-0, 22971923.
38. Jaffer U, Wade RG, Gourlay T. Cytokines in the systemic inflammatory response syndrome: a review. HSR Proc Intensive Care Cardiovasc Anesth 2010, 2:161-175. 3484588, 23441054.
39. Lavi S, Lavi R. Conditioning of the heart: from pharmacological interventions to local and remote protection: possible implications for clinical practice. Int J Cardiol 2011, 146:311-318. 10.1016/j.ijcard.2010.08.010, 20817282.
40. Kuzuya T, Hoshida S, Yamashita N, Fuji H, Oe H, Hori M, Kamada T, Tada M. Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia. Circ Res 1993, 72:1293-1299. 10.1161/01.RES.72.6.1293, 8495557.
41. Hausenloy DJ, Yellon DM. The therapeutic potential of ischemic conditioning: an update. Nat Rev Cardiol 2011, 8:619-629. 10.1038/nrcardio.2011.85, 21691310.
42. Kottenberg E, Thielmann M, Bergmann L, Heine T, Jakob H, Heusch G, Peters J. Protection by remote ischemic preconditioning during coronary artery bypass graft surgery with isoflurane but not propofol - a clinical trial. Acta Anaesthesiol Scand 2012, 56:30-38. 10.1111/j.1399-6576.2011.02585.x, 22103808.